JP2002541833A - ４９個のヒト分泌タンパク質 - Google Patents

４９個のヒト分泌タンパク質

Info

Publication number
JP2002541833A
JP2002541833A JP2000612320A JP2000612320A JP2002541833A JP 2002541833 A JP2002541833 A JP 2002541833A JP 2000612320 A JP2000612320 A JP 2000612320A JP 2000612320 A JP2000612320 A JP 2000612320A JP 2002541833 A JP2002541833 A JP 2002541833A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
sequence
present
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000612320A
Other languages
English (en)
Japanese (ja)
Inventor
クレイグ エイ． ローゼン，
スティーブン エム． ルーベン，
ジョージ コマットソウリス，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of JP2002541833A publication Critical patent/JP2002541833A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2000612320A 1999-03-26 2000-03-23 ４９個のヒト分泌タンパク質 Withdrawn JP2002541833A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US12660199P 1999-03-26 1999-03-26
US15437399P 1999-09-17 1999-09-17
US17606400P 2000-01-14 2000-01-14
US60/126,601 2000-01-14
US60/176,064 2000-01-14
US60/154,373 2000-01-14
PCT/US2000/007677 WO2000063230A2 (fr) 1999-03-26 2000-03-23 49 proteines secretees humaines

Publications (1)

Publication Number Publication Date
JP2002541833A true JP2002541833A (ja) 2002-12-10

Family

ID=27383444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000612320A Withdrawn JP2002541833A (ja) 1999-03-26 2000-03-23 ４９個のヒト分泌タンパク質

Country Status (5)

Country Link
EP (1) EP1171462A2 (fr)
JP (1) JP2002541833A (fr)
AU (1) AU6745700A (fr)
CA (1) CA2364209A1 (fr)
WO (1) WO2000063230A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100535543B1 (ko) * 2002-09-13 2005-12-08 현대자동차주식회사 스로틀 밸브 동결 방지장치

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573095B1 (en) 1998-04-29 2003-06-03 Genesis Research & Development Corporation Limited Polynucleotides isolated from skin cells
CA2398396A1 (fr) * 2000-01-25 2001-08-02 Hyseq, Inc. Methodes et matieres concernant des polypeptides et polynucleotides similaires a alpha de facteur de croissance de transformation
AU2001260847A1 (en) * 2000-05-24 2001-12-03 Genesis Research And Development Corporation Limited Compositions isolated from skin cells and methods for their use
ATE350396T1 (de) * 2001-05-25 2007-01-15 Nymox Corp Von neurofilamentproteinen abgeleitete peptide und deren medizinische verwendung
CN100475843C (zh) 2001-07-19 2009-04-08 尼莫克斯股份有限公司 有效***和其它需要除去或破坏细胞的疾病的肽
EP1847550A3 (fr) * 2001-07-19 2008-01-09 Nymox Corporation Peptides actives dans le traitement des tumeurs et autre conditions requérant la suppression ou la destruction de cellules
US7317077B2 (en) 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100535543B1 (ko) * 2002-09-13 2005-12-08 현대자동차주식회사 스로틀 밸브 동결 방지장치

Also Published As

Publication number Publication date
WO2000063230A2 (fr) 2000-10-26
AU6745700A (en) 2000-11-02
EP1171462A2 (fr) 2002-01-16
WO2000063230A3 (fr) 2001-02-08
CA2364209A1 (fr) 2000-10-26

Similar Documents

Publication Publication Date Title
JP2002538841A (ja) ２７個のヒト分泌タンパク質
JP2002543771A (ja) ６２個のヒト分泌タンパク質
JP2003502058A (ja) ４８個のヒト分泌タンパク質
JP2003502062A (ja) ４９個のヒト分泌タンパク質
JP2002539842A (ja) ４５個のヒト分泌タンパク質
JP2003501011A (ja) ４９個のヒト分泌タンパク質
JP2002541833A (ja) ４９個のヒト分泌タンパク質
JP2003502061A (ja) ４８個のヒト分泌タンパク質
JP2002542766A (ja) ５０個のヒト分泌タンパク質
JP2002543764A (ja) ４６個のヒト分泌タンパク質
JP2003501009A (ja) ４９個のヒト分泌タンパク質
JP2002539814A (ja) ５０個のヒト分泌タンパク質
JP2003501108A (ja) ４７個のヒト分泌タンパク質
JP2002538811A (ja) ４９個のヒト分泌タンパク質
JP2002542767A (ja) ４７個のヒト分泌タンパク質
JP2003500017A (ja) ４８個のヒト分泌タンパク質
JP2002539843A (ja) ５０個のヒト分泌タンパク質
JP2003502038A (ja) ４７個のヒト分泌タンパク質
JP2002539815A (ja) ４７個のヒト分泌タンパク質
JP2002539811A (ja) ４８個のヒト分泌タンパク質
JP2002539778A (ja) ４９個のヒト分泌タンパク質
JP2002539841A (ja) ５０個のヒト分泌タンパク質
JP2002538810A (ja) ５０個のヒト分泌タンパク質
JP2003523726A (ja) ５０個のヒト分泌タンパク質
JP2002541801A (ja) ４８個のヒト分泌タンパク質

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20070605